Invitae (NVTA) has a profit margin of -2.99%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
The latest profit margin for NVTA is -2.99% as of September 2023. That compares with -6.18% in the prior-year period — up 51.6% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Invitae's historical trend and sector peers before judging valuation or financial health.
Over the past year, NVTA's profit margin moved from -6.18% to -2.99% — a 51.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Invitae's valuation or profitability profile.
Against Healthcare companies, NVTA currently prints -2.99% for profit margin, while the sector average sits near 15.58%. That is roughly 2019.5% below the sector mean. Large gaps often invite a closer look at Invitae's growth, margins, and balance sheet.
Profit Margin shows how effectively Invitae converts resources into returns. At -2.99%, NVTA may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6.18% in the prior-year period — up 51.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting NVTA's profit margin (-2.99%), review year-over-year change from -6.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.